PAR paradigm biopharmaceuticals limited..

0.00%

30.0¢

Where are we on a deal?, page-1351

First 1351 Last

Share
Profile

Follow
Hogana123

1,519 Posts.

493

09/06/25

15:28

Post #: 79367031
Share

Originally posted by MixedBag: ↑

I have spoken to a recently retired pharmacist who has been in the pharmaceutical industry for 45 years and is recently retired. She was a hospital pharmacist, then became an owner of a couple of retail pharmacies, before starting a large compound pharmacy business (with several locations) which has recently been sold. She has participated in peer-reviewed research and has sub-contracted her services to a TGA department in the past. A family member of hers has listed two ASX companies in a different sector. This person has also received iPPS treatment and is familiar with the product, PAR.ASX and is VERY VERY familiar with its management (hence the reason I won't name this person).

I asked her about the product and investing in the company. She indicated that it is a good product and she received personal health benefit from using it, as did her husband, and she has seen some of her customers benefit from it and recommends the product. She said it is by no means a miracle drug but it did help her arthritic symptoms, and continues to give her benefit. She has had 2 follow-up doses.

As for investing in it... she refuses to and won't until PR is gone or she sees a rock-solid partnership signed in a medium sized country with a reputable pharmaceutical company

Lack of patent protection (yes, she is very familiar with efforts that have been put in place to attempt to protect from generics) and very poor management are 2 of the main reasons she won't currently invest in it. There were many other reasons listed as well, but not as significant as these two. She is not convinced that PR will get iPPS approved and to market, and also get the support of a large pharmaceutical company.

Personally, I hope she is wrong, however I respect her opinion and reasons.

Expand

Was she very very familiar with PR himself?

What were some of the other reasons for non investment?

PRs going no where so she’ll just have to wait for that deal.

PAR Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

PIQ

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

First 1351 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change 0.000(0.00%)		Mkt cap ! $116.8M

Open	High	Low	Value	Volume
30.0¢	30.5¢	29.5¢	$56.35K	188.1K

Buyers (Bids)

No.	Vol.	Price($)
1	9339	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	14285	1

View Market Depth

No.	Vol.	Price($)
1	9339	0.300
1	30000	0.295
3	84000	0.290
4	104197	0.285
16	249402	0.280

Price($)	Vol.	No.
0.305	14285	1
0.310	16300	3
0.315	94295	4
0.320	127866	10
0.325	112282	5

Last trade - 16.10pm 20/06/2025 (20 minute delay)

PAR (ASX) Chart

Where are we on a deal?, page-1351

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Where are we on a deal?, page-1351

Top Stories

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Proteomics notches up as company launches PromarkerD into the US

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News